45 related articles for article (PubMed ID: 20400237)
1. Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas.
Fan XN; Karsten U; Goletz S; Cao Y
Pathol Res Pract; 2010 Aug; 206(8):585-9. PubMed ID: 20400237
[TBL] [Abstract][Full Text] [Related]
2. PankoMab: a potent new generation anti-tumour MUC1 antibody.
Danielczyk A; Stahn R; Faulstich D; Löffler A; Märten A; Karsten U; Goletz S
Cancer Immunol Immunother; 2006 Nov; 55(11):1337-47. PubMed ID: 16485130
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas.
Fiedler W; DeDosso S; Cresta S; Weidmann J; Tessari A; Salzberg M; Dietrich B; Baumeister H; Goletz S; Gianni L; Sessa C
Eur J Cancer; 2016 Aug; 63():55-63. PubMed ID: 27285281
[TBL] [Abstract][Full Text] [Related]
4. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.
Gellert J; Jäkel A; Danielczyk A; Goletz C; Lischke T; Flechner A; Dix L; Günzl A; Kehler P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338686
[TBL] [Abstract][Full Text] [Related]
5. The Role of Mucin Expression in the Diagnosis of Oesophago-Gastric Cancer: A Systematic Literature Review.
Patel NM; Geropoulos G; Patel PH; Bhogal RH; Harrington KJ; Singanayagam A; Kumar S
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958425
[TBL] [Abstract][Full Text] [Related]
6. An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma.
Houvast RD; Thijse K; Groen JV; Chua J; Vankemmelbeke M; Durrant LG; Mieog JSD; Bonsing BA; Vahrmeijer AL; Kuppen PJK; Crobach ASLP; Sier CFM
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830932
[TBL] [Abstract][Full Text] [Related]
7. Mucin-Type O-GalNAc Glycosylation in Health and Disease.
Bagdonaite I; Pallesen EMH; Nielsen MI; Bennett EP; Wandall HH
Adv Exp Med Biol; 2021; 1325():25-60. PubMed ID: 34495529
[TBL] [Abstract][Full Text] [Related]
8. Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study.
Striefler JK; Riess H; Lohneis P; Bischoff S; Kurreck A; Modest DP; Bahra M; Oettle H; Sinn M; Bläker H; Denkert C; Stintzing S; Sinn BV; Pelzer U
Front Oncol; 2021; 11():670396. PubMed ID: 34386419
[TBL] [Abstract][Full Text] [Related]
9. Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.
Houvast RD; Vankemmelbeke M; Durrant LG; Wuhrer M; Baart VM; Kuppen PJK; de Geus-Oei LF; Vahrmeijer AL; Sier CFM
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371487
[TBL] [Abstract][Full Text] [Related]
10. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy.
Wang S; You L; Dai M; Zhao Y
J Cell Mol Med; 2020 Sep; 24(18):10279-10289. PubMed ID: 32745356
[TBL] [Abstract][Full Text] [Related]
11. Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.
Heublein S; Page S; Mayr D; Schmoeckel E; Trillsch F; Marmé F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642093
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated mucins: role in immune modulation and metastasis.
Bhatia R; Gautam SK; Cannon A; Thompson C; Hall BR; Aithal A; Banerjee K; Jain M; Solheim JC; Kumar S; Batra SK
Cancer Metastasis Rev; 2019 Jun; 38(1-2):223-236. PubMed ID: 30618016
[TBL] [Abstract][Full Text] [Related]
13. Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.
Lwin TM; Hoffman RM; Bouvet M
J Surg Oncol; 2018 Aug; 118(2):253-264. PubMed ID: 30080930
[TBL] [Abstract][Full Text] [Related]
14. TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.
Heublein S; Friese K; Kost B; Marmé F; Kuhn C; Mahner S; Dannecker C; Mayr D; Jeschke U; Vattai A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1899-1907. PubMed ID: 30062487
[TBL] [Abstract][Full Text] [Related]
15. The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.
Lwin TM; Hoffman RM; Bouvet M
Expert Rev Anticancer Ther; 2018 Jul; 18(7):651-662. PubMed ID: 29768067
[TBL] [Abstract][Full Text] [Related]
16. Improving theranostics in pancreatic cancer.
King J; Bouvet M; Singh G; Williams J
J Surg Oncol; 2017 Jul; 116(1):104-113. PubMed ID: 28513912
[TBL] [Abstract][Full Text] [Related]
17. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
Heublein S; Mayr D; Egger M; Karsten U; Goletz S; Angele M; Gallwas J; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2015 May; 34(1):50. PubMed ID: 25986064
[TBL] [Abstract][Full Text] [Related]
19. Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas.
Zhan XX; Zhao B; Diao C; Cao Y; Cheng RC
Endocr Pathol; 2015 Mar; 26(1):21-6. PubMed ID: 25614211
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
